UPSTARNEWS
← 뉴스 목록
enUS

U.S. FDA grants Priority Review for Roche’s Enspryng for MOGAD, an autoimmune disease with no approved treatments

GlobeNewswire (all releases)· www.globenewswire.com
09/10/2026, 05:00 AM
1분 소요